For a story on why PharmDs are an important part of any clinical team, especially with regard to the care complex patients, I'd like to get PharmDs' perspectives on your understanding of the complex landscape of insurance formularies, prior authorizations, and step-therapy requirements and know that a prescription on a chart doesn't guarantee a patient can afford or even get the medication, especially in the case of a medication like a GLP-1, and how your insight can be crucial to predicting non-adherence, which can lead to readmissions and worsened health outcomes. Also with respect to complex patients who have multiple chronic diseases, a medication that helps one condition can negatively impact another; so would like to cover the fact that PharmDs' deep knowledge of pharmacokinetics and pharmacodynamics, allows them to anticipate subtle side effects that could worsen a patient's other health issues - so a GLP-1 causing nausea and vomiting could lead to dehydration and electrolyte imbalance, which is dangerous for a heart failure patient. Finally, the period when a patient leaves the hospital is a high-risk time for medication errors, and PharmDs are trained to serve as medication navigators during this transition. Basically, I want to explore how PharmDs are a critical part of the care team, especially when it comes to complex patients, using those suffering from cardiovascular-kidney-metabolic syndrome as an example.

Looking to speak with Ob-Gyns, Maternal-Fetal and primary care experts

Published on: 9/25/2025

Finance/law/compliance experts needed

Published on: 9/30/2025

Physicians on Being Employed vs. Self Employed

Published on: 9/27/2025

Seeking U.S.-based experts in pulmonology to comment on innovations in COPD and asthma care I am working on a Medscape article about new approaches to managing COPD and asthma that go beyond standard inhaler therapy. I am seeking U.S.-based pulmonologists, researchers, or physicians with experience in pulmonary medicine to share insights on emerging strategies in clinical practice and research. Questions: What innovations in COPD and asthma care are you seeing beyond pharmacotherapy (e.g., breathing techniques, pulmonary rehab, personalized approaches)? Are you using or researching personalized oxygen protocols? If so, how do they compare with standard oxygen therapy? What role do biologic or precision-medicine therapies play in COPD and asthma management today? What barriers exist in implementing these newer approaches (cost, access, adherence)? How can primary care providers best incorporate or refer for these innovations? Looking ahead, what developments are most promising for improving COPD and asthma outcomes over the next 5 years? Consent Note: By responding, you consent to being quoted in a Medscape article with attribution. Quotes may be lightly edited for clarity, style, and flow. Please disclose any potential conflicts of interest (such as financial relationships with relevant companies or organizations).

Published on: 9/27/2025

A physician to discuss the risk of taking too many medications in middle age

Published on: 9/24/2025

20 Pitching Tips to Win Media Coverage in 2025

Real Pitches That Landed Coverage on WSJ, Forbes & More…

Top 12 AI Tools For Better Media Pitching

How to Pitch a Journo Request? (A Complete Beginner's Guide)